Viridian Therapeutics, Inc.VRDNNASDAQ
LOADING
|||
EPS Growth Accelerating
Trending higher, above historical average, slight contraction.
Left:
||||
Year-over-year earnings per share growth rate
Latest
25.05%
↑ 125% above average
Average (9y)
11.15%
Historical baseline
Range
High:78.65%
Low:-53.62%
CAGR
-9.2%
Structural decline
| Period | Value |
|---|---|
| 2024 | 25.05% |
| 2023 | -35.81% |
| 2022 | 41.29% |
| 2021 | 78.65% |
| 2020 | -53.62% |
| 2019 | -22.57% |
| 2018 | 19.80% |
| 2017 | -17.59% |
| 2016 | 16.33% |
| 2015 | 59.97% |